APLM
Price
$19.15
Change
-$3.68 (-16.12%)
Updated
Jun 23, 02:14 PM (EDT)
Capitalization
50.14M
Intraday BUY SELL Signals
MGX
Price
$1.25
Change
+$0.06 (+5.04%)
Updated
Jun 23, 04:09 PM (EDT)
Capitalization
44.8M
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs MGX

APLM vs MGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APLM vs. MGX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (APLM: $22.83 vs. MGX: $1.19)
Brand notoriety: APLM and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 391% vs. MGX: 53%
Market capitalization -- APLM: $50.14M vs. MGX: $44.8M
APLM [@Biotechnology] is valued at $50.14M. MGX’s [@Biotechnology] market capitalization is $44.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, APLM is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 5 TA indicator(s) are bullish while MGX’s TA Score has 4 bullish TA indicator(s).

  • APLM’s TA Score: 5 bullish, 4 bearish.
  • MGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APLM is a better buy in the short-term than MGX.

Price Growth

APLM (@Biotechnology) experienced а +64.84% price change this week, while MGX (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Reported Earning Dates

MGX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLM($50.1M) has a higher market cap than MGX($44.8M). APLM YTD gains are higher at: 22.118 vs. MGX (-26.543). APLM has higher annual earnings (EBITDA): -56.38M vs. MGX (-87.55M). APLM has less debt than MGX: APLM (4.72M) vs MGX (39.2M). MGX has higher revenues than APLM: MGX (22.3M) vs APLM (0).
APLMMGXAPLM / MGX
Capitalization50.1M44.8M112%
EBITDA-56.38M-87.55M64%
Gain YTD22.118-26.543-83%
P/E RatioN/AN/A-
Revenue022.3M-
Total CashN/A140M-
Total Debt4.72M39.2M12%
TECHNICAL ANALYSIS
Technical Analysis
APLMMGX
RSI
ODDS (%)
Bearish Trend 2 days ago
30%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARIIX11.18N/A
N/A
AB Global Real Estate Investment II I
NMCAX17.03N/A
N/A
Voya MidCap Opportunities A
SSCOX6.45N/A
N/A
Touchstone Small Company C
SHSAX62.83N/A
N/A
BlackRock Health Sciences Opps Inv A
MSHOX12.36N/A
N/A
Morgan Stanley Inst Permanence C

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+30.47%
SNTI - APLM
47%
Loosely correlated
+4.91%
HCWB - APLM
45%
Loosely correlated
+6.42%
PRAX - APLM
39%
Loosely correlated
+7.33%
MGX - APLM
37%
Loosely correlated
-0.83%
IPHA - APLM
36%
Loosely correlated
+0.83%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with PRME. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-0.83%
PRME - MGX
50%
Loosely correlated
+4.33%
EDIT - MGX
49%
Loosely correlated
+3.53%
CRBU - MGX
49%
Loosely correlated
+0.18%
RXRX - MGX
49%
Loosely correlated
-2.01%
VYGR - MGX
46%
Loosely correlated
N/A
More